Bank of New York Mellon’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.67M | Buy |
|
|||||
|
2025
Q2 | $1.22M | Sell |
|
|||||
|
2025
Q1 | $1.05M | Buy |
|
|||||
|
2024
Q4 | $1.09M | Sell |
|
|||||
|
2024
Q3 | $976K | Sell |
|
|||||
|
2024
Q2 | $1.28M | Sell |
|
|||||
|
2024
Q1 | $1.45M | Sell |
|
|||||
|
2023
Q4 | $2.21M | Sell |
|
|||||
|
2023
Q3 | $1.75M | Sell |
|
|||||
|
2023
Q2 | $2.24M | Buy |
|
|||||
|
2023
Q1 | $2.28M | Sell |
|
|||||
|
2022
Q4 | $2.37M | Buy |
|
|||||
|
2022
Q3 | $2.08M | Buy |
|
|||||
|
2022
Q2 | $1.65M | Sell |
|
|||||
|
2022
Q1 | $1.81M | Buy |
|
|||||
|
2021
Q4 | $2.08M | Buy |
|
|||||
|
2021
Q3 | $1.31M | Buy |
|
|||||
|
2021
Q2 | $2.55M | Sell |
|
|||||
|
2021
Q1 | $4.13M | Sell |
|
|||||
|
2020
Q4 | $3.66M | Sell |
|
|||||
|
2020
Q3 | $3.12M | Sell |
|
|||||
|
2020
Q2 | $4.52M | Buy |
|
|||||
|
2020
Q1 | $4.88M | Buy |
|
|||||
|
2019
Q4 | $5.26M | Buy |
|
|||||
|
2019
Q3 | $3.84M | Sell |
|
|||||
|
2019
Q2 | $3.39M | Sell |
|
|||||
|
2019
Q1 | $4.74M | Buy |
|
|||||
|
2018
Q4 | $5.33M | Buy |
|
|||||
|
2018
Q3 | $6.72M | Sell |
|
|||||
|
2018
Q2 | $4.67M | Sell |
|
|||||
|
2018
Q1 | $5.09M | Sell |
|
|||||
|
2017
Q4 | $5.88M | Buy |
|
|||||
|
2017
Q3 | $7.2M | Buy |
|
|||||
|
2017
Q2 | $8.27M | Buy |
|
|||||
|
2017
Q1 | $7.59M | Buy |
|
|||||
|
2016
Q4 | $6.4M | Sell |
|
|||||
|
2016
Q3 | $8.04M | Buy |
|
|||||
|
2016
Q2 | $4.08M | Buy |
|
|||||
|
2016
Q1 | $2.69M | Buy |
|
|||||
|
2015
Q4 | $2.31M | Buy |
|
|||||
|
2015
Q3 | $1.41M | Sell |
|
|||||
|
2015
Q2 | $1.68M | Buy |
|
|||||
|
2015
Q1 | $2.06M | Buy |
|
|||||
|
2014
Q4 | $1.74M | Sell |
|
|||||
|
2014
Q3 | $2.78M | Buy |
|
|||||
|
2014
Q2 | $3.83M | Buy |
|